23 hours ago
HHS and VA Sign Agreement to Coordinate Psychedelic Drug Research for Veterans
HHS and the VA established a framework for sharing scientific data to speed up clinical trials. Secretary Collins and Secretary Kennedy signed a memorandum of understanding to improve cooperation on trials for veterans. This agreement aims to facilitate the responsible deployment of future treatments once they receive regulatory approval. Alongside the interagency agreement, the FDA released final guidance for industry regarding clinical investigations of psychedelic drugs. The agency also scheduled a public hearing to gather stakeholder input on the research process. These steps provide a regulatory framework for advancing psychedelic drug trials for patients with serious mental health conditions. FDA issues final guidance on psychedelic drug trialsHHS and VA sign MOU on psychedelic researchHHS and VA partner to accelerate veteran therapiesVA and HHS agreement to advance clinical trials
